Company Financials

GlaxoSmithKline plc Financials

Pound sterling

business GlaxoSmithKline plc Company Profile

Main Stock Listing

LSE: GSK

Market Capitalization £73.73 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 13.72
Forward PE 9.97
Price to Sales TTM £2.29
Price to Book MRQ £454.87
Enterprise to Revenue 2.72
Enterprise to EBITDA 9.19

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 17.08%
Operating Margin 32.61%
Return on Assets TTM 7.13%
Return on Equity TTM 41.52%

Income Statement

Revenue TTM £32,166,000,640
Revenue per Share TTM £7.91
Quarterly Revenue Growth 6.70%
Gross Profit TTM £23,299,000,320
EBITDA £12,262,000,000
Net Income to Common TTM £5,494,000,128
Diluted EPS TTM £1.33
Quarterly Earnings Growth YoY 6.68%

Balance Sheet

Total Cash MRQ £3,305,999,872
Total Cash per Share MRQ £0.82
Total Debt MRQ £
Total Debt to Equity MRQ 112.68
Current Ratio MRQ 0.84
Book Value per Share MRQ £4.01

Cash Flow

Operating Cash Flow TTM £7,792,000,000
Levered Free Cash Flow TTM £3,749,499,904

GSK Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 4,026,337,496
Float Shares 3,900,469,320
Avg 10 Volume 6,913,416
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 2.29%
% Held by Institutions 46.34%

Stock Price Summary

Beta 0.23
Fifty Two Week Low £17.23
Fifty Two Week High £2057.70
Fifty Two Week Change 26.32%
Day 50 MA £1788.82
Day 200 MA £1535.93

Dividends and Splits

Forward Annual Dividend Rate £64.00
Forward Annual Dividend Yield 3.49%
Trailing Annual Dividend Rate £64.00
Trailing Annual Dividend Yield 3.49%
Payout Ratio 47.37%
Dividend Date
Ex Dividend Date 2025-11-13
Last Split Factor
Last Split Date 2022-07-19